Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cholinergic receptor muscarinic 2 | 0.585 | 0.615 | 0.18 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2004 | 2018 | ||||||||
|
cholinergic receptor nicotinic alpha 3 subunit | 0.588 | 0.692 | 1.4E-07 |
|
disease | 0.530 | None | 1.000 | 4 | 0 | 2009 | 2014 | ||||||||
|
cholinergic receptor nicotinic alpha 4 subunit | 0.492 | 0.808 | 8.5E-05 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 2005 | 2019 | ||||||||
|
cholinergic receptor nicotinic alpha 5 subunit | 0.593 | 0.577 | 2.1E-06 |
|
disease | 0.560 | None | 1.000 | 5 | 0 | 2009 | 2019 | ||||||||
|
cholinergic receptor nicotinic beta 3 subunit | 0.705 | 0.308 | 8.6E-06 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2014 | 2017 | ||||||||
|
cholinergic receptor nicotinic beta 4 subunit | 0.644 | 0.423 | 0.14 |
|
disease | 0.330 | None | 1.000 | 3 | 0 | 2009 | 2012 | ||||||||
|
clock circadian regulator | 0.463 | 0.885 | 1.00 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2008 | 2010 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
disease | 0.370 | None | 1.000 | 5 | 0 | 2002 | 2014 | ||||||||
|
cannabinoid receptor 2 | 0.509 | 0.846 | 6.5E-06 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
contactin 4 | 0.653 | 0.577 | 3.3E-06 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
contactin 6 | 0.678 | 0.462 | 9.0E-31 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
contactin associated protein 2 | 0.530 | 0.846 | 2.9E-09 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2014 | 2019 | ||||||||
|
cAMP responsive element binding protein 1 | 0.463 | 0.885 | 1.00 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 2008 | 2014 | ||||||||
|
corticotropin releasing hormone | 0.439 | 0.808 | 0.72 |
|
disease | 0.390 | None | 1.000 | 5 | 0 | 2004 | 2018 | ||||||||
|
corticotropin releasing hormone binding protein | 0.659 | 0.500 | 0.21 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 2008 | 2011 | ||||||||
|
corticotropin releasing hormone receptor 1 | 0.517 | 0.769 | 3.8E-05 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2005 | 2015 | ||||||||
|
catenin alpha 2 | 0.663 | 0.500 | 0.43 |
|
disease | 0.420 | None | 1.000 | 1 | 0 | 2014 | 2019 | ||||||||
|
cytochrome P450 family 2 subfamily A member 13 | 0.695 | 0.462 | 8.6E-07 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
cytochrome P450 family 2 subfamily B member 6 | 0.428 | 0.846 | 1.9E-10 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2003 | 2006 | ||||||||
|
cytochrome P450 family 2 subfamily E member 1 | 0.459 | 0.885 | 8.1E-09 |
|
disease | 0.600 | None | 1.000 | 5 | 0 | 1995 | 2018 | ||||||||
|
cytokine like 1 | 0.700 | 0.423 | 1.1E-05 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
dopamine beta-hydroxylase | 0.511 | 0.846 | 3.3E-10 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1981 | 2014 | ||||||||
|
dickkopf WNT signaling pathway inhibitor 2 | 0.599 | 0.692 | 0.75 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2010 | 2014 | ||||||||
|
dihydropyrimidinase like 2 | 0.585 | 0.692 | 0.99 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
dopamine receptor D1 | 0.529 | 0.808 | 0.96 |
|
disease | 0.330 | None | 0.800 | 5 | 0 | 2003 | 2015 |